In This Section
2021 SNMMI and SNMMI-TS Grants and Awards Recipients
2021 Grants and Awards Recipients (funded by the ERF)
Arthur M. Weis, PhD, Award in Radiation Dosimetry and Safety - Cassandra Miller
Michael J. Welch Award - Victor William Pike, PhD
Michael J. Welch Postdoctoral Grant - Erik Jimmy Jakobsson
Mitzi & William Blahd, MD, Pilot Research Grant - Min-Jeong Kim, MD, PhD
ERF SNMMI Molecular Imaging Research Grant for Junior Academic Faculty - Courtney Lawhn-Heath, MD
ERF SNMMI Postdoctoral Molecular Imaging Scholar Program - Ashwin Singh Parihar, MBBS, MD
ERF-SNMMI CMIIT Laboratory Professional Recognition Award for Contributions to Molecular Imaging - Carmen Azevedo and Anna Fisher
Bradley-Alavi Student Fellowships: Yesh Datar, Shan Srinivas, Servando Hernandez Vargas
Paul C. Aebersold, PhD Award - Steven M. Larson, MD, FACNM
SNMMI JNM Best Paper Awards -
JNM
The Journal of Nuclear Medicine
Editors’ Choice Award
FOR THE BEST CLINICAL ARTICLE IN 2020
is presented to
Clemens Kratochwil, Frederik L. Giesel, Claus-Peter Heussel, Daniel Kazdal, Volker Endris, Cathleen Nientiedt, Frank Bruchertseifer, Maximilian Kippenberger, Hendrik Rathke, Jonas Leichsenring, Markus Hohenfellner, Alfred Morgenstern, Uwe Haberkorn, Stefan Duensing, and Albrecht Stenzinger
Department of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany
for
Patients Resistant Against PSMA-Targeting a-Radiation Therapy Often Harbor Mutations in DNA Damage-Repair–Associated Genes
J Nucl Med. 2020; 61:683–688
The Journal of Nuclear Medicine
Editors’ Choice Award
FOR THE BEST BASIC SCIENCE ARTICLE IN 2020
is presented to
Eric Berg, Herman Gill, Jan Marik, Annie Ogasawara, Simon Williams, Guus van Dongen, Daniëlle Vugts, Simon R. Cherry, and Alice F. Tarantal
Department of Biomedical Engineering, University of California–Davis, Davis, California
for
Total-Body PET and Highly Stable Chelators Together Enable Meaningful 89Zr-Antibody PET Studies up to 30 Days After Injection
J Nucl Med. 2020; 61:453–460
The Journal of Nuclear Medicine
Editors’ Choice Award
FOR THE OVERALL BEST ARTICLE IN 2020
is presented to
Eric Berg, Herman Gill, Jan Marik, Annie Ogasawara, Simon Williams, Guus van Dongen, Daniëlle Vugts, Simon R. Cherry, and Alice F. Tarantal
Department of Biomedical Engineering, University of California–Davis, Davis, California
for
Total-Body PET and Highly Stable Chelators Together Enable Meaningful 89Zr-Antibody PET Studies up to 30 Days After Injection
J Nucl Med. 2020; 61:453–460
2021 Alavi-Mandell Publication Awards for Articles Published in 2020 -
The Impact of Radiobiologically Informed Dose Prescription on the Clinical Benefit of 90Y SIRT in Colorectal Cancer Patients
Elliot M. Abbott*, Nadia Falzone*, Boon Q. Lee, Christiana Kartsonaki, Helen Winter, Tessa A. Greenhalgh, Daniel R. McGowan, Nigar Syed, Ana M. Denis-Bacelar, Philip Boardman, Ricky A. Sharma, and Katherine A. Vallis
Oxford Institute for Radiation Oncology, Department of Oncology, Oxford University, Oxford, United Kingdom
J Nucl Med 2020; 61:1658–1664
Quantitative 3D Assessment of 68Ga-DOTATOC PET/MRI with Diffusion-Weighted Imaging to Assess Imaging Markers for Gastroenteropancreatic Neuroendocrine Tumors: Preliminary Results
Lisa C. Adams*, Keno K. Bressem*, Julia Brangsch, Carolin Reimann, Kristin Nowak, Winfried Brenner, and Marcus R. Makowski
Department of Radiology Charité, Berlin, Germany
J Nucl Med 2020; 61:1021–1027
Cerenkov Luminescence Imaging for Surgical Margins in Radical Prostatectomy: A Surgical Perspective
Dominic Bagguley, Marcus Cumberbatch, Nathan Lawrentschuk, and Declan G. Murphy
Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
J Nucl Med 2020; 61:1498-1499
Differential Expression of Glucose Transporters and Hexokinases in Prostate Cancer with a Neuroendocrine Gene Signature: A Mechanistic Perspective for 18F-FDG Imaging of PSMA-Suppressed Tumors
Martin K. Bakht, Jessica M. Lovnicki, Janice Tubman, Keith F. Stringer, Jonathan Chiaramonte, Michael R. Reynolds, Iulian Derecichei, Rosa-Maria Ferraiuolo, Bre-Anne Fifield, Dorota Lubanska, So Won Oh, Gi Jeong Cheon, Cheol Kwak, Chang Wook Jeong, Keon Wook Kang, John F. Trant, Colm Morrissey, Ilsa M. Coleman, Yuzhuo Wang, Hojjat Ahmadzadehfar, Xuesen Dong, and Lisa A. Porter
Department of Biomedical Sciences, University of Windsor, Windsor, Ontario, Canada
J Nucl Med 2020; 61:904–910
Imaging the Distribution of Gastrin-Releasing Peptide Receptors in Cancer
Lucia Baratto, Heying Duan, Helmut Mäcke, and Andrei Iagaru
Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Stanford University, Stanford, California
J Nucl Med 2020; 61:792–798
11C-Methionine PET Identifies Astroglia Involvement in Heart–Brain Inflammation Networking After Acute Myocardial Infarction
Pablo Bascuñana, Annika Hess, Tobias Borchert, Yong Wang, Kai C. Wollert, Frank M. Bengel, and James T. Thackeray
Department of Nuclear Medicine, Hannover Medical School, Hannover, Germany
J Nucl Med 2020; 61:977–980
First Evidence for a Dose–Response Relationship in Patients Treated with 166Ho Radioembolization: A Prospective Study
Remco Bastiaannet, Caren van Roekel, Maarten L.J. Smits, Sjoerd G. Elias, Wouter A.C. van Amsterdam, Dan Doan, Jip F. Prince, Rutger C.G. Bruijnen, Hugo W.A.M. de Jong, and Marnix G.E.H. Lam
University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
J Nucl Med 2020; 61:608–612
Predictive Value of 18F-Florbetapir and 18F-FDG PET for Conversion from Mild Cognitive Impairment to Alzheimer Dementia
Ganna Blazhenets, Yilong Ma, Arnd Sörensen, Florian Schiller, Gerta Rücker, David Eidelberg, Lars Frings, and Philipp T. Meyer for the Alzheimer Disease Neuroimaging Initiative
Department of Nuclear Medicine, Medical Center–University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
J Nucl Med 2020; 61:597–603
Targeted Optical Imaging of the Glucagonlike Peptide 1 Receptor Using Exendin-4-IRDye 800CW
Marti Boss, Desiree Bos, Cathelijne Frielink, Gerwin Sandker, Selen Ekim, Camille Marciniak, Francois Pattou, Go van Dam, Sanne van Lith, Maarten Brom, Martin Gotthardt, and Mijke Buitinga
Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
J Nucl Med 2020; 61:1066–1071
Receptor-Targeted Photodynamic Therapy of Glucagon-Like Peptide 1 Receptor–Positive Lesions
Marti Boss, Desiree Bos, Cathelijne Frielink, Gerwin Sandker, Patricia Bronkhorst, Sanne A.M. van Lith, Maarten Brom, Mijke Buitinga, and Martin Gotthardt
Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
J Nucl Med 2020; 61:1588–1593
Evaluation of an Automated Module Synthesis and a Sterile Cold Kit–Based Preparation of 68Ga-PSMA-11 in Patients with Prostate Cancer
Letizia Calderoni, Andrea Farolfi, Davide Pianori, Elisa Maietti, Veronica Cabitza, Alessandro Lambertini, Giacomo Ricci, Silvi Telo, Filippo Lodi, Paolo Castellucci, and Stefano Fanti
Nuclear Medicine, St. Orsola Hospital, University of Bologna, Bologna, Italy
J Nucl Med 2020; 61:716–722
64Cu-DOTATATE PET/CT and Prediction of Overall and Progression-Free Survival in Patients with Neuroendocrine Neoplasms
Esben Andreas Carlsen, Camilla Bardram Johnbeck, Tina Binderup, Mathias Loft, Andreas Pfeifer, Jann Mortensen, Peter Oturai, Annika Loft, Anne Kiil Berthelsen, Seppo W. Langer, Ulrich Knigge, and Andreas Kjaer
Department of Clinical Physiology, Nuclear Medicine & PET and Cluster for Molecular Imaging, Department of Biomedical Sciences, Rigshospitalet and University of Copenhagen, Copenhagen, Denmark
J Nucl Med 2020; 61:1491–1497
3D-Printable Platform for High-Throughout Small-Animal Imaging
Lukas M. Carter, Kelly E. Henry, Andre Platzman, and Jason S. Lewis
Memorial Sloan-Kettering Cancer Center, New York, New York
J Nucl Med 2020; 61:1691–1692
Combination Strategies to Improve Targeted Radionuclide Therapy
Tiffany G. Chan, Edward O’Neill, Christine Habjan, and Bart Cornelissen
Department of Oncology, University of Oxford, Oxford, United Kingdom
J Nucl Med 2020; 61:1544–1552
18F-FAC PET Visualizes Brain-Infiltrating Leukocytes in a Mouse Model of Multiple Sclerosis
Bao Ying Chen, Chiara Ghezzi, Brendon Villegas, Andrew Quon, Caius G. Radu, Owen N. Witte, and Peter M. Clark
Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, California
J Nucl Med 2020; 61:757–763
Factors Predicting Metastatic Disease in 68Ga-PSMA-11 PET–Positive Osseous Lesions in Prostate Cancer
Le Wen Chiu, Courtney Lawhn-Heath, Spencer C. Behr, Roxanna Juarez, Paola M. Perez, Iryna Lobach, Matthew D. Bucknor, Thomas A. Hope, and Robert R. Flavell
School of Medicine, University of California San Francisco, San Francisco, California
J Nucl Med 2020; 61:1779–1785
PET Imaging Quantifying 68Ga-PSMA-11 Uptake in Metastatic Colorectal Cancer
Tahleesa J. Cuda, Andrew D. Riddell, Cheng Liu, Vicki L. Whitehall, Jennifer Borowsky, David K. Wyld, Matthew E. Burge, Elizabeth Ahern, Alison Griffin, Nicholas J.R. Lyons, Stephen E. Rose, David A. Clark, Andrew R.L. Stevenson, John D. Hooper, Simon Puttick, and Paul A. Thomas
University of Queensland, Brisbane, Australia
J Nucl Med 2020; 61:1576–1579
Intraoperative 68Ga-PSMA Cerenkov Luminescence Imaging for Surgical Margins in Radical Prostatectomy: A Feasibility Study
Christopher Darr*, Nina N. Harke*, Jan Philipp Radtke, Leubet Yirga, Claudia Kesch, Maarten R. Grootendorst, Wolfgang P. Fendler, Pedro Fragoso Costa, Christoph Rischpler, Christine Praus, Johannes Haubold, Henning Reis, Thomas Hager, Ken Herrmann, Ina Binse*, and Boris Hadaschik*
Department of Urology, University Hospital Essen, Essen, Germany
J Nucl Med 2020; 61:1500–1506
68Ga-PSMA–Guided Bone Biopsies for Molecular Diagnostics in Patients with Metastatic Prostate Cancer
Anouk C. de Jong*, Minke Smits*, Job van Riet, Jurgen J. Fütterer, Tessa Brabander, Paul Hamberg, Inge M. van Oort, Ronald de Wit, Martijn P. Lolkema, Niven Mehra, Marcel Segbers†, and Astrid A.M. van der Veldt†
Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands
J Nucl Med 2020; 61:1607–1614
Back-Table Fluorescence-Guided Imaging for Circumferential Resection Margin Evaluation Using Bevacizumab-800CW in Patients with Locally Advanced Rectal Cancer
Steven J. de Jongh*, Jolien J.J. Tjalma*, Marjory Koller, Matthijs D. Linssen, Jasper Vonk, Michael Dobosz, Annelies Jorritsma-Smit, Jan H. Kleibeuker, Geke A.P. Hospers, Klaas Havenga, Patrick H.J. Hemmer, Arend Karrenbeld, Gooitzen M. van Dam, Boudewijn van Etten, and Wouter B. Nagengast
Department of Gastroenterology and Hepatology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
J Nucl Med 2020; 61:655–661
Diagnostic Accuracy of PET Tracers for the Differentiation of Tumor Progression from Treatment-Related Changes in High-Grade Glioma: A Systematic Review and Metaanalysis
Paul L. de Zwart, Bart R.J. van Dijken, Gea A. Holtman, Gilles N. Stormezand, Rudi A.J.O. Dierckx, Peter Jan van Laar, and Anouk van der Hoorn
Department of Radiology, Medical Imaging Center, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
J Nucl Med 2020; 61:498–504
The Spatial-Temporal Ordering of Amyloid Pathology and Opportunities for PET Imaging
Enrico Fantoni*, Lyduine Collij*, Isadora Lopes Alves, Christopher Buckley, and Gill Farrar on behalf of the AMYPAD consortium
Pharmaceutical Diagnostics, GE Healthcare, Chalfont St. Giles, Buckinghamshire, United Kingdom
J Nucl Med 2020; 61:166–171
Mapping Prostate Cancer Lesions Before and After Unsuccessful Salvage Lymph Node Dissection Using Repeat PSMA PET
Andrea Farolfi, Harun Ilhan, Andrei Gafita, Jeremie Calais, Francesco Barbato, Manuel Weber, Ali Afshar-Oromieh, Fabian Spohn, Axel Wetter, Christoph Rischpler, Boris Hadaschik, Davide Pianori, Stefano Fanti, Uwe Haberkorn, Matthias Eiber, Ken Herrmann*, and Wolfgang Peter Fendler*
Nuclear Medicine Unit, University of Bologna, S. Orsola Hospital, Bologna, Italy
J Nucl Med 2020; 61:1037–1042
Clinical Translation of a 68Ga-Labeled Integrin αvβ6–Targeting Cyclic Radiotracer for PET Imaging of Pancreatic Cancer
Xun Feng, Yanpu Wang, Dehua Lu, Xiaoxia Xu, Xin Zhou, Huiyuan Zhang, Ting Zhang, Hua Zhu, Zhi Yang, Fan Wang, Nan Li, and Zhaofei Liu
Medical Isotopes Research Center and Department of Radiation Medicine, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China
J Nucl Med 2020; 61:1461–1467
Alteration of Cellular Reduction Potential Will Change 64Cu-ATSM Signal With or Without Hypoxia
John M. Floberg, Lingjue Wang, Nilantha Bandara, Ramachandran Rashmi, Cedric Mpoy, Joel R. Garbow, Buck E. Rogers, Gary J. Patti, and Julie K. Schwarz
Department of Radiation Oncology, Washington University, St. Louis, Missouri
J Nucl Med 2020; 61:427–432
Early Prostate-Specific Antigen Changes and Clinical Outcome After 177Lu-PSMA Radionuclide Treatment in Patients with Metastatic Castration-Resistant Prostate Cancer
Andrei Gafita, Matthias M. Heck, Isabel Rauscher, Robert Tauber, Lisena Cala, Charlott Franz, Calogero D’Alessandria, Margitta Retz, Wolfgang A. Weber, and Matthias Eiber
Department of Nuclear Medicine, Technical University of Munich, Klinikum Rechts der Isar, Munich, Germany
J Nucl Med 2020; 61:1476–1483
Multimodality Imaging of Inflammation and Ventricular Remodeling in Pressure-Overload Heart Failure
Aylina Glasenapp, Katja Derlin, Yong Wang, Marion Bankstahl, Martin Meier, Kai C. Wollert, Frank M. Bengel, and James T. Thackeray
Department of Nuclear Medicine, Hannover Medical School, Hannover, Germany
J Nucl Med 2020; 61:590–596
High-Throughput PET/CT Imaging Using a Multiple-Mouse Imaging System
Hannah E. Greenwood, Zoltan Nyitrai, Gabor Mocsai, Sandor Hobor, and Timothy H. Witney
Centre for Advanced Biomedical Imaging, Division of Medicine, University College London, London, United Kingdom
J Nucl Med 2020; 61:292–297
Pharmacokinetic Assessment of 18F-(2S,4R)-4-Fluoroglutamine in Patients with Cancer
Milan Grkovski, Reema Goel, Simone Krebs, Kevin D. Staton, James J. Harding, Ingo K. Mellinghoff, John L. Humm, and Mark P.S. Dunphy
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York
J Nucl Med 2020; 61:357–366
Demarcation of Sepsis-Induced Peripheral and Central Acidosis with pH (Low) Insertion Cycle Peptide
Kelly E. Henry, Aisling M. Chaney, Veronica L. Nagle, Haley C. Cropper, Saghar Mozaffari, Gregory Slaybaugh, Keykavous Parang, Oleg A. Andreev, Yana K. Reshetnyak, Michelle L. James, and Jason S. Lewis
Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
J Nucl Med 2020; 61:1361–1368
Hybrid Tracers Based on Cyanine Backbones Targeting Prostate-Specific Membrane Antigen: Tuning Pharmacokinetic Properties and Exploring Dye–Protein Interaction
Albertus W. Hensbergen, Tessa Buckle, Danny M. van Willigen, Margret Schottelius, Mick M. Welling, Felicia A. van der Wijk, Tobias Maurer, Henk G. van der Poel, Gabri van der Pluijm, Wytske M. van Weerden, Hans-Jürgen Wester, and Fijs W.B. van Leeuwen
Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands
J Nucl Med 2020; 61:234–241.
177Lu-NM600 Targeted Radionuclide Therapy Extends Survival in Syngeneic Murine Models of Triple-Negative Breast Cancer
Reinier Hernandez, Joseph J. Grudzinski, Eduardo Aluicio-Sarduy, Christopher F. Massey, Anatoly N. Pinchuk, Ariana N. Bitton, Ravi Patel, Ray Zhang, Aakarsha V. Rao, Gopal Iyer, Jonathan W. Engle, and Jamey P. Weichert
Department of Radiology, University of Wisconsin–Madison, Madison, Wisconsin
J Nucl Med 2020; 61:1187–1194
Tumor-to-Blood Ratio for Assessment of Somatostatin Receptor Density in Neuroendocrine Tumors Using 68Ga-DOTATOC and 68Ga-DOTATATE
Ezgi Ilan, Irina Velikyan, Mattias Sandström, Anders Sundin*, and Mark Lubberink*
Section of Nuclear Medicine and PET, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden
J Nucl Med 2020; 61:217–221
Folate Receptor β–Targeted PET Imaging of Macrophages in Autoimmune Myocarditis
Arghavan Jahandideh, Sauli Uotila, Mia Ståhle, Jenni Virta, Xiang-Guo Li, Ville Kytö, Päivi Marjamäki, Heidi Liljenbäck, Pekka Taimen, Vesa Oikonen, Jukka Lehtonen, Mikko I. Mäyränpää, Qingshou Chen, Philip S. Low, Juhani Knuuti, Anne Roivainen, and Antti Saraste
Turku PET Centre, University of Turku, Turku, Finland
J Nucl Med 2020; 61:1643–1649
Neuroinflammation PET Imaging: Current Opinion and Future Directions
Poorva Jain, Aisling M. Chaney, Mackenzie L. Carlson, Isaac M. Jackson, Anoushka Rao, and Michelle L. James
Department of Radiology, Molecular Imaging Program at Stanford, Stanford University, Stanford, California
J Nucl Med 2020; 61:1107–1112
Lesion Detection and Interobserver Agreement with Advanced Image Reconstruction for 18F-DCFPyL PET/CT in Patients with Biochemically Recurrent Prostate Cancer
Bernard H.E. Jansen, Robin W. Jansen, Maurits Wondergem, Sandra Srbljin, John M.H. de Klerk, Birgit I. Lissenberg-Witte, André N. Vis, Reindert J.A. van Moorselaar, Ronald Boellaard, Otto S. Hoekstra, and Daniela E. Oprea-Lager
Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
J Nucl Med 2020; 61:210–216
Repeatability of Quantitative 18F-DCFPyL PET/CT Measurements in Metastatic Prostate Cancer
Bernard H.E. Jansen, Matthijs C.F. Cysouw, André N. Vis, Reindert J.A. van Moorselaar, Jens Voortman, Yves J.L. Bodar, Patrick R. Schober, N. Harry Hendrikse, Otto S. Hoekstra, Ronald Boellaard, and D.E. Oprea-Lager
Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam University Medical Centers, VU University, Amsterdam, The Netherlands
J Nucl Med 2020; 61:1320–1325
Pulmonary Lymphangitic Carcinomatosis: Diagnostic Performance of High-Resolution CT and 18F-FDG PET/CT in Correlation with Clinical Pathologic Outcome
Mario Jreige*, Vincent Dunet*, Igor Letovanec, John O. Prior, Reto A. Meuli, Catherine Beigelman-Aubry, and Niklaus Schaefer
Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital, Lausanne, Switzerland
J Nucl Med 2020; 61:26–32
Imaging Inflammation in Atherosclerosis with CXCR4-Directed 68Ga-Pentixafor PET/CT: Correlation with 18F-FDG PET/CT
Malte Kircher, Johannes Tran-Gia, Luisa Kemmer, Xiaoli Zhang, Andreas Schirbel, Rudolf A. Werner, Andreas K. Buck, Hans-Jürgen Wester, Marcus Hacker, Constantin Lapa*, and Xiang Li*
Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany
J Nucl Med 2020; 61:751–756
Light-Induced Radiosynthesis of 89Zr-DFO-Azepin-Onartuzumab for Imaging the Hepatocyte Growth Factor Receptor
Simon Klingler, Rachael Fay, and Jason P. Holland
Department of Chemistry, University of Zurich, Zurich, Switzerland
J Nucl Med 2020; 61:1072–1078
Performance of Digital PET Compared with High-Resolution Conventional PET in Patients with Cancer
Daniëlle Koopman, Jorn. A. van Dalen, Henk Stevens, Cornelis H. Slump, Siert Knollema, and Pieter L. Jager
Department of Nuclear Medicine, Isala, Zwolle, The Netherlands
J Nucl Med 2020; 61:1448–1454
Histologically Confirmed Diagnostic Efficacy of 18F-rhPSMA-7 PET for N-Staging of Patients with Primary High-Risk Prostate Cancer
Markus Kroenke, Alexander Wurzer, Kristina Schwamborn, Lena Ulbrich, Lena Jooß, Tobias Maurer, Thomas Horn, Isabel Rauscher, Bernhard Haller, Michael Herz, Hans-Jürgen Wester, Wolfgang A. Weber, and Matthias Eiber
Department of Nuclear Medicine, School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
J Nucl Med 2020; 61:710–715
Detection Rate and Localization of Prostate Cancer Recurrence Using 68Ga-PSMA-11 PET/MRI in Patients with Low PSA Values ≤ 0.5 ng/mL
Benedikt Kranzbühler, Julian Müller, Anton S. Becker, Helena I. Garcia Schüler, Urs Muehlematter, Christian D. Fankhauser, Sarah Kedzia, Matthias Guckenberger, Philipp A. Kaufmann, Daniel Eberli, and Irene A. Burger
Department of Urology, University Hospital Zürich, University of Zürich, Zürich, Switzerland
J Nucl Med 2020; 61:194–201
Recent Advances in Imaging Steroid Hormone Receptors in Breast Cancer
Manoj Kumar, Kelley Salem, Amye J. Tevaarwerk, Roberta M. Strigel, and Amy M. Fowler
Department of Radiology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin
J Nucl Med 2020; 61:172–176
Head-to-Head Comparison of 68Ga-PSMA-11 with 18F-PSMA-1007 PET/CT in Staging Prostate Cancer Using Histopathology and Immunohistochemical Analysis as a Reference Standard
Jonathan Kuten, Ibrahim Fahoum, Ziv Savin, Ofer Shamni, Gilad Gitstein, Dov Hershkovitz, Nicola J. Mabjeesh, Ofer Yossepowitch, Eyal Mishani, and Einat Even-Sapir
Department of Nuclear Medicine, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
J Nucl Med 2020; 61:527–532
Immune Checkpoint Imaging in Oncology: A Game Changer Toward Personalized Immunotherapy?
Susanne Lütje, Georg Feldmann, Markus Essler, Peter Brossart, and Ralph A. Bundschuh
Department of Nuclear Medicine, University Hospital Bonn, Bonn, Germany
J Nucl Med 2020; 61:1137–1144
High-Resolution Depth-Encoding PET Detector Module with Prismatoid Light-Guide Array
Andy LaBella, Xinjie Cao, Eric Petersen, Rick Lubinsky, Anat Biegon, Wei Zhao, and Amir H. Goldan
Department of Biomedical Engineering, College of Engineering and Applied Sciences, Stony Brook University, Stony Brook, New York
J Nucl Med 2020; 61:1528–1533
PARP-1–Targeted Auger Emitters Display High-LET Cytotoxic Properties In Vitro but Show Limited Therapeutic Utility in Solid Tumor Models of Human Neuroblastoma
Hwan Lee, Aladdin Riad, Paul Martorano, Adam Mansfield, Minu Samanta, Vandana Batra, Robert H. Mach, John M. Maris, Daniel A. Pryma, and Mehran Makvandi
Department of Radiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania
J Nucl Med 2020; 61:850–856
Multiparametric 18F-FDG PET/MRI of the Breast: Are There Differences in Imaging Biomarkers of Contralateral Healthy Tissue Between Patients With and Without Breast Cancer?
Doris Leithner, Thomas H. Helbich, Blanca Bernard-Davila, Maria Adele Marino, Daly Avendano, Danny F. Martinez, Maxine S. Jochelson, Panagiotis Kapetas, Pascal A.T. Baltzer, Alexander Haug, Marcus Hacker, Yasemin Tanyildizi, Elizabeth A. Morris, and Katja Pinker
Department of Radiology, Breast Imaging Service, Memorial Sloan Kettering Cancer Center, New York, New York
J Nucl Med 2020; 61:20–25
18F-FDG PET/CT Identifies Predictors of Survival in Patients with Locally Advanced Cervical Carcinoma and Paraaortic Lymph Node Involvement to Allow Intensification of Treatment
Hélène Leray, Erwan Gabiache, Frédéric Courbon, Isabelle Brenot-Rossi, Hélène Colineaux, Benoît Lepage, Eric Lambaudie, Alejandra Martinez, Marie Voglimacci, Ariane Weyl, Marion Deslandres, Anne Ducassou, Stéphanie Motton, Charlotte Vaysse, and Elodie Chantalat
Department of Surgical Oncology, IUCT-Oncopole, Toulouse, France
J Nucl Med 2020; 61:1442–1447
Dose-Dependent Growth Delay of Breast Cancer Xenografts in the Bone Marrow of Mice Treated with 223Ra: The Role of Bystander Effects and Their Potential for Therapy
Calvin N. Leung, Brian S. Canter, Didier Rajon, Tom A. Bäck, J. Christopher Fritton, Edouard I. Azzam, and Roger W. Howell
Department of Radiology, New Jersey Medical School, Rutgers University, Newark, New Jersey
J Nucl Med 2020; 61:89–95
The Roach Equation: Value of Old Clinical Tools in the Era of New Molecular Imaging
Yun Rose Li and Mack Roach
Department of Radiation Oncology and Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California
J Nucl Med 2010; 61:1292–1293
The Genetic Duet of BRAF V600E and TERT Promoter Mutations Robustly Predicts Loss of Radioiodine Avidity in Recurrent Papillary Thyroid Cancer
Jiajun Liu*, Rengyun Liu*, Xiaopei Shen, Guangwu Zhu, Biao Li, and Mingzhao Xing
Laboratory for Cellular and Molecular Thyroid Research, Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland
J Nucl Med 2020; 61:177–182
68Ga-PSMA PET/CT Combined with PET/Ultrasound-Guided Prostate Biopsy Can Diagnose Clinically Significant Prostate Cancer in Men with Previous Negative Biopsy Results
Chen Liu*, Teli Liu*, Zhongyi Zhang*, Ning Zhang, Peng Du, Yong Yang, Yiqiang Liu, Wei Yu, Nan Li, Michael A. Gorin, Steven P. Rowe, Hua Zhu, Kun Yan, and Zhi Yang
Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing, China
J Nucl Med 2020; 61:1314–1319
A Clinical Feasibility Study to Image Angiogenesis in Patients with Arteriovenous Malformations Using 68Ga-RGD PET/CT
Daphne Lobeek, Frédérique C.M. Bouwman, Erik H.J.G. Aarntzen, Janneke D.M. Molkenboer-Kuenen, Uta E. Flucke, Ha-Long Nguyen, Miikka Vikkula, Laurence M. Boon, Willemijn Klein, Peter Laverman, Wim J.G. Oyen, Otto C. Boerman, Samantha Y.A. Terry, Leo J. Schultze Kool, and Mark Rijpkema
Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
J Nucl Med 2020; 61:270–275
177Lu-Lilotomab Satetraxetan Has the Potential to Counteract Resistance to Rituximab in Non-Hodgkin Lymphoma
Marion M. Malenge, Sebastian Patzke, Anne H. Ree, Trond Stokke, Peter Ceuppens, Brian Middleton, Jostein Dahle, and Ada H.V. Repetto-Llamazares
Nordic Nanovector ASA, Oslo, Norway
J Nucl Med 2020; 61:1468–1475
Confirmation of 123I-FP-CIT SPECT Quantification Methods in Dementia with Lewy Bodies and Other Neurodegenerative Disorders
Daniela D. Maltais, Lennon G. Jordan, Hoon-Ki Min, Toji Miyagawa, Scott A. Przybelski, Timothy G. Lesnick, Robert R. Reichard, Dennis W. Dickson, Melissa E. Murray, Kejal Kantarci, Bradley F. Boeve, and Val J. Lowe
Department of Radiology, Mayo Clinic, Rochester, Minnesota
J Nucl Med 2020; 61:1628–1635
Characterization of 3 PET Tracers for Quantification of Mitochondrial and Synaptic Function in Healthy Human Brain: 18F-BCPP-EF, 11C-SA-4503, and 11C-UCB-J
Ayla Mansur, Eugenii A. Rabiner, Robert A. Comley, Yvonne Lewis, Lefkos T. Middleton, Mickael Huiban, Jan Passchier, Hideo Tsukada, and Roger N. Gunn for the MIND-MAPS Consortium
Invicro LLC, London, United Kingdom
J Nucl Med 2020; 61:96–103
PET/MRI Versus PET/CT for Whole-Body Staging: Results from a Single-Center Observational Study on 1,003 Sequential Examinations
Ole Martin*, Benedikt M. Schaarschmidt*, Julian Kirchner, Saravanabavaan Suntharalingam, Johannes Grueneisen, Aydin Demircioglu, Philipp Heusch, Harald H. Quick, Michael Forsting, Gerald Antoch, Ken Herrmann, and Lale Umutlu
Department of Diagnostic and Interventional Radiology, Medical Faculty, University Dusseldorf, Dusseldorf, Germany
J Nucl Med 2020; 61:1131–1136
An 89Zr-HDL PET Tracer Monitors Response to a CSF1R Inhibitor
Christian A. Mason, Susanne Kossatz, Lukas M. Carter, Giacomo Pirovano, Christian Brand, Navjot Guru, Carlos Pérez-Medina, Jason S. Lewis, Willem J.M. Mulder, and Thomas Reiner
Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
J Nucl Med 2020; 61:433–436
Standardization of Preclinical PET/CT Imaging to Improve Quantitative Accuracy, Precision, and Reproducibility: A Multicenter Study
Wendy McDougald, Christian Vanhove, Adrienne Lehnert, Barbara Lewellen, John Wright, Marco Mingarelli, Carlos Alcaide Corral, Jurgen E. Schneider, Sven Plein, David E. Newby, Andy Welch, Robert Miyaoka, Stefaan Vandenberghe, and Adriana Alexandre S. Tavares
BHF-Centre for Cardiovascular Science, College of Medicine & Veterinary Medicine, Queen’s Medical Research Institute, University of Edinburgh, United Kingdom
J Nucl Med 2020; 61:461–468
Can Intraoperative Fluorescence Imaging Identify All Lesions While the Road Map Created by Preoperative Nuclear Imaging Is Masked?
Phillipa Meershoek, Tessa Buckle, Matthias N. van Oosterom, Gijs H. KleinJan, Henk G. van der Poel, and Fijs W.B. van Leeuwen
Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands
J Nucl Med 2020; 61:834–841
Radiation Dosimetry and Biodistribution of 68Ga-FAPI-46 PET Imaging in Cancer Patients
Catherine Meyer, Magnus Dahlbom, Thomas Lindner, Sebastien Vauclin, Christine Mona, Roger Slavik, Johannes Czernin, Uwe Haberkorn, and Jeremie Calais
Physics and Biology in Medicine Interdepartmental Graduate Program, David Geffen School of Medicine, UCLA, Los Angeles, California
J Nucl Med 2020; 61:1171–1177
11C-Choline PET/CT in Recurrent Prostate Cancer: Retrospective Analysis in a Large U.S. Patient Series
Laure Michaud, Karim A. Touijer, Audrey Mauguen, Michael J. Zelefsky, Michael J. Morris, Serge K. Lyashschenko, Jeremy C. Durack, John L. Humm, Wolfgang A. Weber, and Heiko Schöder
Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
J Nucl Med 2020; 61:827–833
Comparative Prognostic and Diagnostic Value of Myocardial Blood Flow and Myocardial Flow Reserve After Cardiac Transplantation
Robert J.H. Miller*, Osamu Manabe*, Balaji Tamarappoo, Sean Hayes, John D. Friedman, Piotr J. Slomka, Jignesh Patel, Jon A. Kobashigawa, and Daniel S. Berman
Departments of Imaging and Medicine, Cedars-Sinai Medical Center, Los Angeles, California
J Nucl Med 2020; 61:249–255
Repurposing Molecular Imaging and Sensing for Cancer Image–Guided Surgery
Suman B. Mondal*, Christine M. O’Brien*, Kevin Bishop, Ryan C. Fields, Julie A. Margenthaler, and Samuel Achilefu
Department of Radiology, Washington University, St. Louis, Missouri
J Nucl Med 2020; 61:1113–1122
18F-FDG PET/CT in the Diagnostic and Treatment Evaluation of Pediatric Posttransplant Lymphoproliferative Disorders
Filipe M. Montes de Jesus, Andor W.J.M. Glaudemans, Wim J. Tissing, Rudi A.J.O. Dierckx, Stefano Rosati, Arjan Diepstra, Walter Noordzij, and Thomas C. Kwee
Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
J Nucl Med 2020; 61:1307–1313
Imaging Responses to Immunotherapy with Novel PET Tracers
Anna-Larissa Niemeijer, Otto S. Hoekstra, Egbert F. Smit, and Adrianus J. de Langen
Department of Pulmonary Diseases, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
J Nucl Med 2020; 61:641–642
Quantitative and Qualitative Analyses of Biodistribution and PET Image Quality of a Novel Radiohybrid PSMA, 18F-rhPSMA-7, in Patients with Prostate Cancer
So Won Oh, Alexander Wurzer, Eugene J. Teoh, Sohee Oh, Thomas Langbein, Markus Krönke, Michael Herz, Saskia Kropf, Hans-Jürgen Wester, Wolfgang A. Weber, and Matthias Eiber
Department of Nuclear Medicine, School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
J Nucl Med 2020; 61:702–709
18F-DCFPyL PET/CT in Patients with Subclinical Recurrence of Prostate Cancer: Effect of Lesion Size, Smoothing Filter, and Partial-Volume Correction on PROMISE Criteria
Claudia Ortega*, Josh Schaefferkoetter*, Patrick Veit-Haibach, Reut Anconina, Alejandro Berlin, Nathan Perlis, and Ur Metser
Joint Department of Medical Imaging, Princess Margaret Hospital, University Health Network, Mount Sinai Hospital and Women’s College Hospital, University of Toronto, Toronto, Ontario, Canada
J Nucl Med 2020; 61:1615–1620
Inflammation-Based Index and 68Ga-DOTATOC PET–Derived Uptake and Volumetric Parameters Predict Outcome in Neuroendocrine Tumor Patients Treated with 90Y-DOTATOC
Elin Pauwels, Sofie Van Binnebeek, Vincent Vandecaveye, Kristof Baete, Hubert Vanbilloen, Michel Koole, Felix M. Mottaghy, Karin Haustermans, Paul M. Clement, Kristiaan Nackaerts, Eric Van Cutsem, Chris Verslype, and Christophe M. Deroose
Nuclear Medicine, University Hospitals Leuven, and Department of Imaging and Pathology, KU Leuven, Leuven, Belgium
J Nucl Med 2020; 61:1014–1020
PET/CT Imaging with an 18F-Labeled Galactodendritic Unit in a Galectin-1–Overexpressing Orthotopic Bladder Cancer Model
Patricia M.R. Pereira*, Sheryl Roberts*, Flávio Figueira, João P.C. Tomé, Thomas Reiner, and Jason S. Lewis
Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
J Nucl Med 2020; 61:1369–1375
Experimental Multicenter and Multivendor Evaluation of the Performance of PET Radiomic Features Using 3-Dimensionally Printed Phantom Inserts
Elisabeth Pfaehler, Joyce van Sluis, Bram B.J. Merema, Peter van Ooijen, Ralph C.M. Berendsen, Floris H.P. van Velden, and Ronald Boellaard
Department of Nuclear Medicine and Molecular Imaging, Medical Imaging Center, University Medical Center Groningen, Groningen, The Netherlands
J Nucl Med 2020; 61:469–476
Optical Imaging Modalities: Principles and Applications in Preclinical Research and Clinical Settings
Giacomo Pirovano, Sheryl Roberts, Susanne Kossatz, and Thomas Reiner
Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
J Nucl Med 2020; 61:1419–1427
Nuclear Imaging of Bacterial Infection: The State of the Art and Future Directions
Ilona Polvoy, Robert R. Flavell, Oren S. Rosenberg, Michael A. Ohliger, and David M. Wilson
Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California
J Nucl Med 2020; 61:1708–1716
Total-Body 68Ga-PSMA-11 PET/CT for Bone Metastasis Detection in Prostate Cancer Patients: Potential Impact on Bone Scan Guidelines
Kelsey L. Pomykala, Johannes Czernin, Tristan R. Grogan, Wesley R. Armstrong, John Williams, and Jeremie Calais
Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, California
J Nucl Med 2020; 61:405–411
First-Line Selective Internal Radiation Therapy in Patients with Uveal Melanoma Metastatic to the Liver
Alexandre Ponti, Alban Denys, Antonia Digklia, Niklaus Schaefer, Arnaud Hocquelet, Jean-François Knebel, Olivier Michielin, Clarisse Dromain, and Rafael Duran
Department of Radiology and Interventional Radiology, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland
J Nucl Med 2020; 61:350–356
Synthesis of the PET Tracer 124I-Trametinib for MAPK/ERK Kinase Distribution and Resistance Monitoring
Edwin C. Pratt, Elizabeth Isaac, Evan P. Stater, Guangbin Yang, Ouathek Ouerfelli, Nagavarakishore Pillarsetty, and Jan Grimm
Department of Pharmacology, Weill Cornell Graduate School, New York, New York
J Nucl Med 2020; 61:1845–1850
Response Prediction of 177Lu-PSMA-617 Radioligand Therapy Using Prostate-Specific Antigen, Chromogranin A, and Lactate Dehydrogenase
Hendrik Rathke, Tim Holland-Letz, Walter Mier, Paul Flechsig, Eleni Mavriopoulou, Manuel Röhrich, Klaus Kopka, Markus Hohenfellner, Frederik Lars Giesel, Uwe Haberkorn, and Clemens Kratochwil
Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany
J Nucl Med 2020; 61:689–695
Matched-Pair Comparison of 68Ga-PSMA-11 and 18F-PSMA-1007 PET/CT: Frequency of Pitfalls and Detection Efficacy in Biochemical Recurrence After Radical Prostatectomy
Isabel Rauscher, Markus Krönke, Michael König, Andrei Gafita, Tobias Maurer, Thomas Horn, Kilian Schiller, Wolfgang Weber, and Matthias Eiber
Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
J Nucl Med 2020; 61:51–57
Can the Injected Dose Be Reduced in 68Ga-PSMA-11 PET/CT While Maintaining High Image Quality for Lesion Detection?
Isabel Rauscher, Wolfgang P. Fendler, Thomas A. Hope, Andrew Quon, Stephan G. Nekolla, Jeremie Calais, Antonia Richter, Bernhard Haller, Ken Herrmann, Wolfgang A. Weber, Johannes Czernin, and Matthias Eiber
Department of Nuclear Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany
J Nucl Med 2020; 61:189–193
Integrity of Neurocognitive Networks in Dementing Disorders as Measured with Simultaneous PET/Functional MRI
Isabelle Ripp, Thomas Stadhouders, Alexandre Savio, Oliver Goldhardt, Jorge Cabello, Vince Calhoun, Valentin Riedl, Dennis Hedderich, Janine Diehl-Schmid, Timo Grimmer, and Igor Yakushev
Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
J Nucl Med 2020; 61:1341–1347
Total-Body PET Imaging for up to 30 Days After Injection of 89Zr-Labeled Antibodies
Zachary T. Rosenkrans and Weibo Cai
Department of Pharmaceutical Sciences, University of Wisconsin–Madison, Madison, Wisconsin
J Nucl Med 2020; 61:451–452
Comparison Between 18F-FDG PET–Based and CT-Based Criteria in Non–Small Cell Lung Cancer Patients Treated with Nivolumab
Giovanni Rossi, Matteo Bauckneht, Carlo Genova, Erika Rijavec, Federica Biello, Simone Mennella, Maria Giovanna Dal Bello, Giuseppe Cittadini, Paolo Bruzzi, Roberta Piva, Valentina Ceriani, Gianmario Sambuceti, Egesta Lopci, Silvia Morbelli, and Francesco Grossi
Lung Cancer Unit, IRCCS Policlinico San Martino, Genoa, Italy
J Nucl Med 2020; 61:990–998
Asymmetry of Fibrillar Plaque Burden in Amyloid Mouse Models
Christian Sacher, Tanja Blume, Leonie Beyer, Gloria Biechele, Julia Sauerbeck, Florian Eckenweber, Maximilian Deussing, Carola Focke, Samira Parhizkar, Simon Lindner, Franz-Josef Gildehaus, Barbara von Ungern-Sternberg, Karlheinz Baumann, Sabina Tahirovic, Gernot Kleinberger, Michael Willem, Christian Haass, Peter Bartenstein, Paul Cumming, Axel Rominger, Jochen Herms, and Matthias Brendel
Department of Nuclear Medicine, University Hospital of Munich, Ludwig Maximilian University Munich, Munich, Germany
J Nucl Med 2020; 61:1825–1831
Projection Space Implementation of Deep Learning–Guided Low-Dose Brain PET Imaging Improves Performance over Implementation in Image Space
Amirhossein Sanaat, Hossein Arabi, Ismini Mainta, Valentina Garibotto, and Habib Zaidi
Division of Nuclear Medicine and Molecular Imaging, Geneva University Hospital, Geneva, Switzerland
J Nucl Med 2020; 61:1388–1396
Preclinical PERCIST and 25% of SUVmax Threshold: Precision Imaging of Response to Therapy in Co-clinical 18F-FDG PET Imaging of Triple-Negative Breast Cancer Patient–Derived Tumor Xenografts
Madhusudan A. Savaikar, Timothy Whitehead, Sudipta Roy, Lori Strong, Nicole Fettig, Tina Prmeau, Jingqin Luo, Shunqiang Li, Richard L. Wahl, and Kooresh I. Shoghi
Department of Radiology, Washington University School of Medicine, St. Louis, Missouri
J Nucl Med 2020; 61:842–849
Additional Local Therapy for Liver Metastases in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Systemic PSMA-Targeted Therapy
Robert Seifert, Katharina Kessel, Martin Boegemann, Michael Köhler, Wolfgang Roll, Lars Stegger, Matthias Weckesser, and Kambiz Rahbar
Department of Nuclear Medicine, University Hospital Münster, Münster, Germany
J Nucl Med 2020; 61:723–728
Semiautomatically Quantified Tumor Volume Using 68Ga-PSMA-11 PET as a Biomarker for Survival in Patients with Advanced Prostate Cancer
Robert Seifert, Ken Herrmann, Jens Kleesiek, Michael Schäfers, Vijay Shah, Zhoubing Xu, Guillaume Chabin, Sasa Grbic, Bruce Spottiswoode, and Kambiz Rahbar
Department of Nuclear Medicine, University Hospital Münster, Münster, Germany
J Nucl Med 2020; 61:1786–1792
PET Imaging of the Natural Killer Cell Activation Receptor NKp30
Travis M. Shaffer, Amin Aalipour, Christian M. Schürch, and Sanjiv S. Gambhir
Department of Radiology, Stanford University, Stanford, California
J Nucl Med 2020; 61:1348–1354
Promise of Fully Integrated PET/MRI: Noninvasive Clinical Quantification of Cerebral Glucose Metabolism
Lalith Kumar Shiyam Sundar, Otto Muzik, Lucas Rischka, Andreas Hahn, Rupert Lanzenberger, Marius Hienert, Eva-Maria Klebermass, Martin Bauer, Ivo Rausch, Ekaterina Pataraia, Tatjana Traub-Weidinger, and Thomas Beyer
QIMP Team, Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Austria
J Nucl Med 2020; 61:276–284
18F-FDG PET/CT in Left-Ventricular Assist Device Infection: Initial Results Supporting the Usefulness of Image-Guided Therapy
Jan M. Sommerlath Sohns*, Hannah Kröhn*, Alexandra Schöde, Thorsten Derlin, Axel Haverich, Jan D. Schmitto*, and Frank M. Bengel*
Department of Nuclear Medicine, Hannover Medical School, Hannover, Germany
J Nucl Med 2020; 61:971–976
Prospective Evaluation of 18F-DCFPyL PET/CT in Biochemically Recurrent Prostate Cancer in an Academic Center: A Focus on Disease Localization and Changes in Management
Hong Song, Caitlyn Harrison, Heying Duan, Kip Guja, Negin Hatami, Benjamin L. Franc, Farshad Moradi, Carina Mari Aparici, Guido A. Davidzon, and Andrei Iagaru
Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Stanford University, Stanford, California
J Nucl Med 2020; 61:546–551
18F-FDG PET Imaging of the Inferior Colliculus in Asymmetric Hearing Loss
Iva Speck, Susan Arndt, Johannes Thurow, Ganna Blazhenets, Antje Aschendorff, Philipp T. Meyer, and Lars Frings
Department of Otorhinolaryngology–Head and Neck Surgery, Faculty of Medicine, University of Freiburg Medical Center, Freiburg, Germany
J Nucl Med 2020; 61:418–422
Molecular Imaging of PD-L1 Expression and Dynamics with the Adnectin-Based PET Tracer 18F-BMS-986192
Thijs S. Stutvoet*, Elly L. van der Veen*, Arjan Kol, Inês F. Antunes, Erik F.J. de Vries, Geke A.P. Hospers, Elisabeth G.E. de Vries, Steven de Jong, and Marjolijn N. Lub-de Hooge
Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
J Nucl Med 2020; 61:1839–1844
The Biodistribution of a CD3 and EpCAM Bispecific T-Cell Engager Is Driven by the CD3 Arm
Frans V. Suurs, Grit Lorenczewski, Sabine Stienen, Matthias Friedrich, Elisabeth G.E. de Vries, Derk Jan A. de Groot, and Marjolijn N. Lub-de Hooge
Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands
J Nucl Med 2020; 61:1594–1601
Targeting Fibroblast Activation Protein: Radiosynthesis and Preclinical Evaluation of an 18F-Labeled FAP Inhibitor
Johannes Toms, Jürgen Kogler, Simone Maschauer, Christoph Daniel, Christian Schmidkonz, Torsten Kuwert, and Olaf Prante
Friedrich-Alexander University Erlangen-Nurnberg (FAU), Department of Nuclear Medicine, Molecular Imaging and Radiochemistry, Translational Research Center, Erlangen, Germany
J Nucl Med 2020; 61:1806–1813
ABCG2- and ABCB1 Inhibition Using Supratherapeutic Doses of Erlotinib: Clinical Implications in the Treatment of Central Nervous System Metastases
Eveline A. van de Stradt, Maqsood Yaqub, Idris Bahce, and N.H. Hendrikse
Amsterdam UMC, Amsterdam, Netherlands
J Nucl Med 2020; 61:305
Development and Evaluation of Interleukin-2–Derived Radiotracers for PET Imaging of T Cells in Mice
Elly L. van der Veen, Frans V. Suurs, Frederik Cleeren, Guy Bormans, Philip H. Elsinga, Geke A.P. Hospers, Marjolijn N. Lub-de Hooge, Elisabeth G.E. de Vries, Erik F.J. de Vries, and Inês F. Antunes
Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
J Nucl Med 2020; 61:1355–1360
Image Quality and Semiquantitative Measurements on the Biograph Vision PET/CT System: Initial Experiences and Comparison with the Biograph mCT
Joyce van Sluis, Ronald Boellaard, Ananthi Somasundaram, Paul H. van Snick, Ronald J.H. Borra, Rudi A.J.O. Dierckx, Gilles N. Stormezand, Andor W.J.M. Glaudemans, and Walter Noordzij
Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
J Nucl Med 2020; 61:129–135
Image Quality and Activity Optimization in Oncologic 18F-FDG PET Using the Digital Biograph Vision PET/CT System
Joyce van Sluis, Ronald Boellaard, Rudi A.J.O. Dierckx, Gilles N. Stormezand, Andor W.J.M. Glaudemans, and Walter Noordzij
Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
J Nucl Med 2020; 61:764–771
TSPO Versus P2X7 as a Target for Neuroinflammation: An In Vitro and In Vivo Study
Donatienne Van Weehaeghe, Evelien Van Schoor, Joke De Vocht, Michel Koole, Bala Attili, Sofie Celen, Lieven Declercq, Dietmar R. Thal, Philip Van Damme, Guy Bormans, and Koen Van Laere
Division of Nuclear Medicine, Department of Imaging and Pathology, University Hospitals Leuven, KU Leuven, Leuven, Belgium
J Nucl Med 2020; 61:604–607
Moving Toward Multicenter Therapeutic Trials in Amyotrophic Lateral Sclerosis: Feasibility of Data Pooling Using Different Translocator Protein PET Radioligands
Donatienne Van Weehaeghe*, Suma Babu*, Joke De Vocht, Nicole R. Zürcher, Sheena Chew, Chieh-En J. Tseng, Marco L. Loggia, Michel Koole, Ahmadreza Rezaei, Georg Schramm, Philip Van Damme, Jacob M. Hooker, Koen Van Laere*, and Nazem Atassi*
Nuclear Medicine Subdivision, Department of Imaging and Pathology, University Hospital Leuven, Leuven, Belgium
J Nucl Med 2020; 61:1621–1627
Management of Patients with Renal Failure Undergoing Dialysis During 131I Therapy for Thyroid Cancer
Maximilien Vermandel*, Pauline Debruyne*, Amandine Beron, Laura Devos, Antoine Talbot, Jean-François Legrand, François Provôt, and Georges Lion
Nuclear Medicine Department, Hospital Salengro, CHU de Lille, Lille, France
J Nucl Med 2020; 61:1161–1170
Diagnostic Value of 68Ga-PSMA PET/CT for Detection of Phosphatase and Tensin Homolog Expression in Prostate Cancer: A Pilot Study
BaoJun Wang*, Jie Gao*, Qing Zhang*, Yao Fu, Guangxiang Liu, Jiong Shi, Danyan Li, Feng Wang*, and Hongqian Guo
Department of Urology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Institute of Urology Nanjing University, Jiangsu Province, China
J Nucl Med 2020; 61:873–880
A Prospective, Comparative Study of Ventilation–Perfusion Planar Imaging and Ventilation–Perfusion SPECT for Chronic Thromboembolic Pulmonary Hypertension
Lei Wang, Meng Wang, Tao Yang, Dayong Wu, Changming Xiong*, and Wei Fang*
Department of Nuclear Medicine, Fuwai Hospital, National Centre for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Beijing, China
J Nucl Med 2020; 61:1832–1838
The Changing Face of Nuclear Cardiology: Guiding Cardiovascular Care Toward Molecular Medicine
Rudolf A. Werner, James T. Thackeray, Johanna Diekmann, Desiree Weiberg, Johann Bauersachs, and Frank M. Bengel
Department of Nuclear Medicine, Hannover Medical School, Hannover, Germany
J Nucl Med 2020; 61:951–961
Nationwide Survey on Implementation of 2011 Nuclear Regulatory Commission Policy on Release of Patients After 131I Therapy for Thyroid Cancer
Di Wu, Cristiane J. Gomes Lima, Gary Bloom, Kenneth D. Burman, Leonard Wartofsky, and Douglas Van Nostrand
MedStar Health Research Institute, Hyattsville, Maryland
J Nucl Med 2020; 61:397–404
Radiohybrid Ligands: A Novel Tracer Concept Exemplified by 18F- or 68Ga-Labeled rhPSMA Inhibitors
Alexander Wurzer, Daniel Di Carlo, Alexander Schmidt, Roswitha Beck, Matthias Eiber, Markus Schwaiger, and Hans-Jürgen Wester
Chair of Pharmaceutical Radiochemistry, Technical University of Munich, Garching, Germany
J Nucl Med 2020; 61:735–742
Predictive Role of Temporal Changes in Intratumoral Metabolic Heterogeneity During Palliative Chemotherapy in Patients with Advanced Pancreatic Cancer: A Prospective Cohort Study
Shin Hye Yoo*, Seo Young Kang*, Gi Jeong Cheon, Do-Youn Oh, and Yung-Jue Bang
Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea
J Nucl Med 2020; 61:33–39
Label-Free Visualization of Early Cancer Hepatic Micrometastasis and Intraoperative Image-Guided Surgery by Photoacoustic Imaging
Qian Yu*, Shanshan Huang*, Zhiyou Wu, Jiadi Zheng, Xiaoyuan Chen, and Liming Nie
State Key Laboratory of Molecular Vaccinology and Molecular Diagnosis and Center for Molecular Imaging and Translational Medicine, School of Public Health, Xiamen University, Xiamen, China
J Nucl Med 2020; 61:1079–1085
177Lu-EB-PSMA Radioligand Therapy with Escalating Doses in Patients with Metastatic Castration-Resistant Prostate Cancer
Jie Zang*, Qingxing Liu*, Huimin Sui, Rongxi Wang, Orit Jacobson, Xinrong Fan, Zhaohui Zhu, and Xiaoyuan Chen
Department of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China
J Nucl Med 2020; 61:1772–1778
Imaging P-Glycoprotein Induction at the Blood–Brain Barrier of a β-Amyloidosis Mouse Model with 11C-Metoclopramide PET
Viktoria Zoufal, Severin Mairinger, Mirjam Brackhan, Markus Krohn, Thomas Filip, Michael Sauberer, Johann Stanek, Thomas Wanek, Nicolas Tournier, Martin Bauer, Jens Pahnke, and Oliver Langer
Preclinical Molecular Imaging, AIT Austrian Institute of Technology GmbH, Seibersdorf, Austria
J Nucl Med 2020; 61:1050–1057
Susan C. Weiss Clinical Advancement Scholarship - Sarah Frye, MBA, CNMT, (PET)(NCT), CCRP and Nicholas Heath, CNMT
ERF-SNMMI-TS Bachelor's or Master's Degree Completion Scholarship - Derrick Gillan, ARRT(N)(MR)(CT)PET
ERF-SNMMI-TS Advanced Degree Scholarship - Sarah Gibbons, CNMT, NMTCB(CT) and Nicholas Heath, ARRT (N)(R)
Paul Cole Student Technologist Scholarship - Fatimah Almuallim, Bridgette Asuquo, Anna Beam, Brandon Nielson, Harmun Sehmby, Lori Smith, Jackie Stevens, Eileen Tang, Khalil Webb, Madelyn Zimmer
ERF-SNMMI-TS Outstanding Technologist - Sarah Gibbons, CNMT, NMTCB(CT)
Kathy Thompson Hunt Outstanding Educator Award - Jennifer L. Prekeges, MS, CNMT, FSNMMI-TS
ERF-SNMMI-TS JNMT Best Paper Awards -
Journal of Nuclear Medicine Technology
Editors’ Choice Award
FOR 1ST PLACE ARTICLE IN 2020
is presented to
Paul E. Christian, Simon-Peter Williams, Lance Burrell, Paulo Castaneda, Justin Albiani, Nicholas Sandella, Andrei Iagaru, John M. Hoffman, Alex de Crespigny, and Sandra Sanabria Bohorquez
Genentech, Inc., South San Francisco, California
for
Optimization of 89Zr PET Imaging for Improved Multisite Quantification and Lesion Detection Using an Anthropomorphic Phantom
- Nucl. Med. Technol. 2020; 48:54–57
Journal of Nuclear Medicine Technology
Editors’ Choice Award
FOR 2ND PLACE ARTICLE IN 2020
is presented to
Shirin Hatami, Sarah Frye, Anna McMunn, Crystal Botkin, Razi Muzaffar, Kara Christopher, and Medhat Osman
Doisy College of Health Sciences, Saint Louis University, St. Louis, Missouri
for
Added Value of Digital over Analog PET/CT: More Significant as Image Field of View and Body Mass Index Increase
- Nucl. Med. Technol. 2020; 48:354–360
Journal of Nuclear Medicine Technology
Editors’ Choice Award
FOR 3RD PLACE ARTICLE IN 2020
is presented to
Krista Wolfe, Jonathan Baldwin, Vesper Grantham, and Wendy Galbraith
College of Allied Health, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
for
90Y-Labeled Resin Microsphere Spills: A Pilot Study to Determine Efficient Cleanup Practices
- Nucl. Med. Technol. 2020; 48:274–277
Journal of Nuclear Medicine Technology
Editors’ Choice Award
FOR BEST CONTINUING EDUCATION ARTICLE IN 2020
is presented to
Barbara J. Grabher
Grabher Consulting and Specialty Services, Forest Hill, Maryland
for
Breast Cancer: Evaluating Tumor Estrogen Receptor Status with Molecular Imaging to Increase Response to Therapy and Improve Patient Outcomes
- Nucl. Med. Technol. 2020; 48:191–201
Journal of Nuclear Medicine Technology
Editors’ Choice Award
FOR BEST EDUCATORS’ FORUM ARTICLE IN 2020
is presented to
Gail A. McFarland, Richard G. Hoylman, Jennifer L. Prekeges, and Vanessa R. Bennett
Nuclear Medicine Technology Program, Bellevue College, Bellevue, Washington
for
Teaching Professional Behavior
- Nucl. Med. Technol. 2020; 48:317–325
2021 Grants and Awards Recipients (funded by the Nihon Medi-Physics)
2021-2023 Wagner-Torizuka Fellowship Program - Yoshito Kadoya, MD
2021 Grant Recipients (funded by the SNMMI Value Initiative)
Medical and Science Student Research Grant - Yesh Datar, Shadab Ahamed, Bryan Fraser, Vishnu Murthy, Temitope Agabalogun, Kevin Cheng, Kevin Leung, David Gao, Abhijit Bhattaru, Nathan Wright
2021 Grants and Awards Recipients (funded by the PDEF)
PDEF Mickey Williams Minority Scholarship - Ann Apo and Ricky Huang
PDEF Professional Development Scholarship - Mary Beth Farrell, MS, CNMT, NCT, FSNMMI-TS
2021 Council and Center Awards
Saul Hertz Award - Eric Krenning, MD, PhD, FRCP
Peter E. Valk, MD Memorial Lecuteship/Award - Rodney J. Hicks, MD
GCNMC Lifetime Achievement Award - Harvey Ziessman, MD, FSNMMI
GCNMC Lectureship Award - Philip Wells, MD, FRCPC, MSc
CIC Barry Siegel Lectureship Award - Ora Israel, Sr., MD, FSNMMI
Tracey Lynn Faber Award - Shiva Abbaszadh, PhD
Edward Hoffman Lecture Award - Ramsey Badawi, PhD
Kuhl Lassen Award - Julie Price, PhD
Berson-Yalow Award - Ashley Cherie Knight, M.Sc
Hermann Blumgart Award - Robert DeKemp, PhD
CVC Outstanding Educator Award - Panithaya Chareonthaitawee, MD
Tom Miller Memorial Lectureship Award - Paige Bennett, MD
AC Distinguished Service Award - Twyla Bartel, DO, MBA, FACNM
PIC Conway-Treves Award - Helen Nadel, MD